Global Stem Cell Therapy Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Page: 106

Published Date: 26 Jan 2021

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Stem Cell Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Stem Cell Therapy size is estimated to be USD 1005 million in 2026 from USD 503.7 million in 2020, with a change XX% between 2020 and 2021. The global Stem Cell Therapy market size is expected to grow at a CAGR of 18.9% for the next five years.

Market segmentation
Stem Cell Therapy market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Autologous
    Allogeneic

Market segment by Application, can be divided into
    Musculoskeletal Disorder
    Wounds & Injuries
    Cornea
    Cardiovascular Diseases
    Others

Market segment by players, this report covers
    Osiris Therapeutics
    NuVasive
    Chiesi Pharmaceuticals
    JCR Pharmaceutical
    Pharmicell
    Medi-post
    Anterogen
    Molmed
    Takeda (TiGenix)

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Stem Cell Therapy
    1.2 Classification of Stem Cell Therapy by Type
        1.2.1 Overview: Global Stem Cell Therapy Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global Stem Cell Therapy Revenue Market Share by Type in 2020
        1.2.3 Autologous
        1.2.4 Allogeneic
    1.3 Global Stem Cell Therapy Market by Application
        1.3.1 Overview: Global Stem Cell Therapy Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Musculoskeletal Disorder
        1.3.3 Wounds & Injuries
        1.3.4 Cornea
        1.3.5 Cardiovascular Diseases
        1.3.6 Others
    1.4 Global Stem Cell Therapy Market Size & Forecast
    1.5 Global Stem Cell Therapy Market Size and Forecast by Region
        1.5.1 Global Stem Cell Therapy Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global Stem Cell Therapy Market Size by Region, (2016-2021)
        1.5.3 North America Stem Cell Therapy Market Size and Prospect (2016-2026)
        1.5.4 Europe Stem Cell Therapy Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific Stem Cell Therapy Market Size and Prospect (2016-2026)
        1.5.6 South America Stem Cell Therapy Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa Stem Cell Therapy Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Stem Cell Therapy Market Drivers
        1.6.2 Stem Cell Therapy Market Restraints
        1.6.3 Stem Cell Therapy Trends Analysis

2 Company Profiles
    2.1 Osiris Therapeutics
        2.1.1 Osiris Therapeutics Details
        2.1.2 Osiris Therapeutics Major Business
        2.1.3 Osiris Therapeutics Stem Cell Therapy Product and Solutions
        2.1.4 Osiris Therapeutics Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 Osiris Therapeutics Recent Developments and Future Plans
    2.2 NuVasive
        2.2.1 NuVasive Details
        2.2.2 NuVasive Major Business
        2.2.3 NuVasive Stem Cell Therapy Product and Solutions
        2.2.4 NuVasive Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 NuVasive Recent Developments and Future Plans
    2.3 Chiesi Pharmaceuticals
        2.3.1 Chiesi Pharmaceuticals Details
        2.3.2 Chiesi Pharmaceuticals Major Business
        2.3.3 Chiesi Pharmaceuticals Stem Cell Therapy Product and Solutions
        2.3.4 Chiesi Pharmaceuticals Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 Chiesi Pharmaceuticals Recent Developments and Future Plans
    2.4 JCR Pharmaceutical
        2.4.1 JCR Pharmaceutical Details
        2.4.2 JCR Pharmaceutical Major Business
        2.4.3 JCR Pharmaceutical Stem Cell Therapy Product and Solutions
        2.4.4 JCR Pharmaceutical Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 JCR Pharmaceutical Recent Developments and Future Plans
    2.5 Pharmicell
        2.5.1 Pharmicell Details
        2.5.2 Pharmicell Major Business
        2.5.3 Pharmicell Stem Cell Therapy Product and Solutions
        2.5.4 Pharmicell Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 Pharmicell Recent Developments and Future Plans
    2.6 Medi-post
        2.6.1 Medi-post Details
        2.6.2 Medi-post Major Business
        2.6.3 Medi-post Stem Cell Therapy Product and Solutions
        2.6.4 Medi-post Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 Medi-post Recent Developments and Future Plans
    2.7 Anterogen
        2.7.1 Anterogen Details
        2.7.2 Anterogen Major Business
        2.7.3 Anterogen Stem Cell Therapy Product and Solutions
        2.7.4 Anterogen Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 Anterogen Recent Developments and Future Plans
    2.8 Molmed
        2.8.1 Molmed Details
        2.8.2 Molmed Major Business
        2.8.3 Molmed Stem Cell Therapy Product and Solutions
        2.8.4 Molmed Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.8.5 Molmed Recent Developments and Future Plans
    2.9 Takeda (TiGenix)
        2.9.1 Takeda (TiGenix) Details
        2.9.2 Takeda (TiGenix) Major Business
        2.9.3 Takeda (TiGenix) Stem Cell Therapy Product and Solutions
        2.9.4 Takeda (TiGenix) Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.9.5 Takeda (TiGenix) Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Stem Cell Therapy Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Stem Cell Therapy Players Market Share
        3.2.2 Top 10 Stem Cell Therapy Players Market Share
        3.2.3 Market Competition Trend
    3.3 Stem Cell Therapy Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type
    4.1 Global Stem Cell Therapy Revenue and Market Share by Type (2016-2021)
    4.2 Global Stem Cell Therapy Market Forecast by Type (2021-2026)

5 Market Size Segment by Application
    5.1 Global Stem Cell Therapy Revenue Market Share by Application (2016-2021)
    5.2 Stem Cell Therapy Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application
    6.1 North America Stem Cell Therapy Revenue by Type (2016-2026)
    6.2 North America Stem Cell Therapy Revenue by Application (2016-2026)
    6.3 North America Stem Cell Therapy Market Size by Country
        6.3.1 North America Stem Cell Therapy Revenue by Country (2016-2026)
        6.3.2 United States Stem Cell Therapy Market Size and Forecast (2016-2026)
        6.3.3 Canada Stem Cell Therapy Market Size and Forecast (2016-2026)
        6.3.4 Mexico Stem Cell Therapy Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application
    7.1 Europe Stem Cell Therapy Revenue by Type (2016-2026)
    7.2 Europe Stem Cell Therapy Revenue by Application (2016-2026)
    7.3 Europe Stem Cell Therapy Market Size by Country
        7.3.1 Europe Stem Cell Therapy Revenue by Country (2016-2026)
        7.3.2 Germany Stem Cell Therapy Market Size and Forecast (2016-2026)
        7.3.3 France Stem Cell Therapy Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom Stem Cell Therapy Market Size and Forecast (2016-2026)
        7.3.5 Russia Stem Cell Therapy Market Size and Forecast (2016-2026)
        7.3.6 Italy Stem Cell Therapy Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Stem Cell Therapy Revenue by Type (2016-2026)
    8.2 Asia-Pacific Stem Cell Therapy Revenue by Application (2016-2026)
    8.3 Asia-Pacific Stem Cell Therapy Market Size by Region
        8.3.1 Asia-Pacific Stem Cell Therapy Revenue by Region (2016-2026)
        8.3.2 China Stem Cell Therapy Market Size and Forecast (2016-2026)
        8.3.3 Japan Stem Cell Therapy Market Size and Forecast (2016-2026)
        8.3.4 South Korea Stem Cell Therapy Market Size and Forecast (2016-2026)
        8.3.5 India Stem Cell Therapy Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia Stem Cell Therapy Market Size and Forecast (2016-2026)
        8.3.7 Australia Stem Cell Therapy Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application
    9.1 South America Stem Cell Therapy Revenue by Type (2016-2026)
    9.2 South America Stem Cell Therapy Revenue by Application (2016-2026)
    9.3 South America Stem Cell Therapy Market Size by Country
        9.3.1 South America Stem Cell Therapy Revenue by Country (2016-2026)
        9.3.2 Brazil Stem Cell Therapy Market Size and Forecast (2016-2026)
        9.3.3 Argentina Stem Cell Therapy Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Stem Cell Therapy Revenue by Type (2016-2026)
    10.2 Middle East & Africa Stem Cell Therapy Revenue by Application (2016-2026)
    10.3 Middle East & Africa Stem Cell Therapy Market Size by Country
        10.3.1 Middle East & Africa Stem Cell Therapy Revenue by Country (2016-2026)
        10.3.2 Turkey Stem Cell Therapy Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia Stem Cell Therapy Market Size and Forecast (2016-2026)
        10.3.4 UAE Stem Cell Therapy Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Stem Cell Therapy Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
    Table 2. Global Stem Cell Therapy Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
    Table 3. Global Market Stem Cell Therapy Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
    Table 4. Global Stem Cell Therapy Revenue (USD Million) by Region (2016-2021)
    Table 5. Global Stem Cell Therapy Revenue Market Share by Region (2021-2026)
    Table 6. Osiris Therapeutics Corporate Information, Head Office, and Major Competitors
    Table 7. Osiris Therapeutics Major Business
    Table 8. Osiris Therapeutics Stem Cell Therapy Product and Solutions
    Table 9. Osiris Therapeutics Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 10. NuVasive Corporate Information, Head Office, and Major Competitors
    Table 11. NuVasive Major Business
    Table 12. NuVasive Stem Cell Therapy Product and Solutions
    Table 13. NuVasive Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 14. Chiesi Pharmaceuticals Corporate Information, Head Office, and Major Competitors
    Table 15. Chiesi Pharmaceuticals Major Business
    Table 16. Chiesi Pharmaceuticals Stem Cell Therapy Product and Solutions
    Table 17. Chiesi Pharmaceuticals Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 18. JCR Pharmaceutical Corporate Information, Head Office, and Major Competitors
    Table 19. JCR Pharmaceutical Major Business
    Table 20. JCR Pharmaceutical Stem Cell Therapy Product and Solutions
    Table 21. JCR Pharmaceutical Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 22. Pharmicell Corporate Information, Head Office, and Major Competitors
    Table 23. Pharmicell Major Business
    Table 24. Pharmicell Stem Cell Therapy Product and Solutions
    Table 25. Pharmicell Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 26. Medi-post Corporate Information, Head Office, and Major Competitors
    Table 27. Medi-post Major Business
    Table 28. Medi-post Stem Cell Therapy Product and Solutions
    Table 29. Medi-post Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 30. Anterogen Corporate Information, Head Office, and Major Competitors
    Table 31. Anterogen Major Business
    Table 32. Anterogen Stem Cell Therapy Product and Solutions
    Table 33. Anterogen Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 34. Molmed Corporate Information, Head Office, and Major Competitors
    Table 35. Molmed Major Business
    Table 36. Molmed Stem Cell Therapy Product and Solutions
    Table 37. Molmed Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 38. Takeda (TiGenix) Corporate Information, Head Office, and Major Competitors
    Table 39. Takeda (TiGenix) Major Business
    Table 40. Takeda (TiGenix) Stem Cell Therapy Product and Solutions
    Table 41. Takeda (TiGenix) Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 42. Global Stem Cell Therapy Revenue (USD Million) by Players (2019-2021)
    Table 43. Global Stem Cell Therapy Revenue Share by Players (2019-2021)
    Table 44. Breakdown of Stem Cell Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
    Table 45. Stem Cell Therapy Players Head Office, Products and Services Provided
    Table 46. Stem Cell Therapy Mergers & Acquisitions in the Past Five Years
    Table 47. Stem Cell Therapy New Entrants and Expansion Plans
    Table 48. Global Stem Cell Therapy Revenue (USD Million) by Type (2016-2021)
    Table 49. Global Stem Cell Therapy Revenue Share by Type (2016-2021)
    Table 50. Global Stem Cell Therapy Revenue Forecast by Type (2021-2026)
    Table 51. Global Stem Cell Therapy Revenue by Application (2016-2021)
    Table 52. Global Stem Cell Therapy Revenue Forecast by Application (2021-2026)
    Table 53. North America Stem Cell Therapy Revenue by Type (2016-2021) & (USD Million)
    Table 54. North America Stem Cell Therapy Revenue by Type (2021-2026) & (USD Million)
    Table 55. North America Stem Cell Therapy Revenue by Application (2016-2021) & (USD Million)
    Table 56. North America Stem Cell Therapy Revenue by Application (2021-2026) & (USD Million)
    Table 57. North America Stem Cell Therapy Revenue by Country (2016-2021) & (USD Million)
    Table 58. North America Stem Cell Therapy Revenue by Country (2021-2026) & (USD Million)
    Table 59. Europe Stem Cell Therapy Revenue by Type (2016-2021) & (USD Million)
    Table 60. Europe Stem Cell Therapy Revenue by Type (2021-2026) & (USD Million)
    Table 61. Europe Stem Cell Therapy Revenue by Application (2016-2021) & (USD Million)
    Table 62. Europe Stem Cell Therapy Revenue by Application (2021-2026) & (USD Million)
    Table 63. Europe Stem Cell Therapy Revenue by Country (2016-2021) & (USD Million)
    Table 64. Europe Stem Cell Therapy Revenue by Country (2021-2026) & (USD Million)
    Table 65. Asia-Pacific Stem Cell Therapy Revenue by Type (2016-2021) & (USD Million)
    Table 66. Asia-Pacific Stem Cell Therapy Revenue by Type (2021-2026) & (USD Million)
    Table 67. Asia-Pacific Stem Cell Therapy Revenue by Application (2016-2021) & (USD Million)
    Table 68. Asia-Pacific Stem Cell Therapy Revenue by Application (2021-2026) & (USD Million)
    Table 69. Asia-Pacific Stem Cell Therapy Revenue by Region (2016-2021) & (USD Million)
    Table 70. Asia-Pacific Stem Cell Therapy Revenue by Region (2021-2026) & (USD Million)
    Table 71. South America Stem Cell Therapy Revenue by Type (2016-2021) & (USD Million)
    Table 72. South America Stem Cell Therapy Revenue by Type (2021-2026) & (USD Million)
    Table 73. South America Stem Cell Therapy Revenue by Application (2016-2021) & (USD Million)
    Table 74. South America Stem Cell Therapy Revenue by Application (2021-2026) & (USD Million)
    Table 75. South America Stem Cell Therapy Revenue by Country (2016-2021) & (USD Million)
    Table 76. South America Stem Cell Therapy Revenue by Country (2021-2026) & (USD Million)
    Table 77. Middle East & Africa Stem Cell Therapy Revenue by Type (2016-2021) & (USD Million)
    Table 78. Middle East & Africa Stem Cell Therapy Revenue by Type (2021-2026) & (USD Million)
    Table 79. Middle East & Africa Stem Cell Therapy Revenue by Application (2016-2021) & (USD Million)
    Table 80. Middle East & Africa Stem Cell Therapy Revenue by Application (2021-2026) & (USD Million)
    Table 81. Middle East & Africa Stem Cell Therapy Revenue by Country (2016-2021) & (USD Million)
    Table 82. Middle East & Africa Stem Cell Therapy Revenue by Country (2021-2026) & (USD Million)
List of Figures
    Figure 1. Stem Cell Therapy Picture
    Figure 2. Global Stem Cell Therapy Revenue Market Share by Type in 2020
    Figure 3. Autologous
    Figure 4. Allogeneic
    Figure 5. Stem Cell Therapy Revenue Market Share by Application in 2020
    Figure 6. Musculoskeletal Disorder Picture
    Figure 7. Wounds & Injuries Picture
    Figure 8. Cornea Picture
    Figure 9. Cardiovascular Diseases Picture
    Figure 10. Others Picture
    Figure 11. Global Stem Cell Therapy Revenue, (USD Million): 2020 VS 2021 VS 2026
    Figure 12. Global Stem Cell Therapy Revenue and Forecast (2016-2026) & (USD Million)
    Figure 13. Global Stem Cell Therapy Revenue Market Share by Region (2016-2026)
    Figure 14. Global Stem Cell Therapy Revenue Market Share by Region in 2020
    Figure 15. North America Stem Cell Therapy Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 16. Europe Stem Cell Therapy Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 17. Asia-Pacific Stem Cell Therapy Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 18. South America Stem Cell Therapy Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 19. Middle East and Africa Stem Cell Therapy Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 20. Stem Cell Therapy Market Drivers
    Figure 21. Stem Cell Therapy Market Restraints
    Figure 22. Stem Cell Therapy Market Trends
    Figure 23. Osiris Therapeutics Recent Developments and Future Plans
    Figure 24. NuVasive Recent Developments and Future Plans
    Figure 25. Chiesi Pharmaceuticals Recent Developments and Future Plans
    Figure 26. JCR Pharmaceutical Recent Developments and Future Plans
    Figure 27. Pharmicell Recent Developments and Future Plans
    Figure 28. Medi-post Recent Developments and Future Plans
    Figure 29. Anterogen Recent Developments and Future Plans
    Figure 30. Molmed Recent Developments and Future Plans
    Figure 31. Takeda (TiGenix) Recent Developments and Future Plans
    Figure 32. Global Stem Cell Therapy Revenue Share by Players in 2020
    Figure 33. Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    Figure 34. Global Top 3 Players Stem Cell Therapy Revenue Market Share in 2020
    Figure 35. Global Top 10 Players Stem Cell Therapy Revenue Market Share in 2020
    Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
    Figure 37. Global Stem Cell Therapy Revenue Share by Type in 2020
    Figure 38. Global Stem Cell Therapy Market Share Forecast by Type (2021-2026)
    Figure 39. Global Stem Cell Therapy Revenue Share by Application in 2020
    Figure 40. Global Stem Cell Therapy Market Share Forecast by Application (2021-2026)
    Figure 41. North America Stem Cell Therapy Sales Market Share by Type (2016-2026)
    Figure 42. North America Stem Cell Therapy Sales Market Share by Application (2016-2026)
    Figure 43. North America Stem Cell Therapy Revenue Market Share by Country (2016-2026)
    Figure 44. United States Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 45. Canada Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 46. Mexico Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 47. Europe Stem Cell Therapy Sales Market Share by Type (2016-2026)
    Figure 48. Europe Stem Cell Therapy Sales Market Share by Application (2016-2026)
    Figure 49. Europe Stem Cell Therapy Revenue Market Share by Country (2016-2026)
    Figure 50. Germany Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 51. France Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 52. United Kingdom Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 53. Russia Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 54. Italy Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 55. Asia-Pacific Stem Cell Therapy Sales Market Share by Type (2016-2026)
    Figure 56. Asia-Pacific Stem Cell Therapy Sales Market Share by Application (2016-2026)
    Figure 57. Asia-Pacific Stem Cell Therapy Revenue Market Share by Region (2016-2026)
    Figure 58. China Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 59. Japan Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 60. South Korea Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 61. India Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 62. Southeast Asia Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 63. Australia Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 64. South America Stem Cell Therapy Sales Market Share by Type (2016-2026)
    Figure 65. South America Stem Cell Therapy Sales Market Share by Application (2016-2026)
    Figure 66. South America Stem Cell Therapy Revenue Market Share by Country (2016-2026)
    Figure 67. Brazil Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 68. Argentina Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 69. Middle East and Africa Stem Cell Therapy Sales Market Share by Type (2016-2026)
    Figure 70. Middle East and Africa Stem Cell Therapy Sales Market Share by Application (2016-2026)
    Figure 71. Middle East and Africa Stem Cell Therapy Revenue Market Share by Country (2016-2026)
    Figure 72. Turkey Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 73. Saudi Arabia Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 74. UAE Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 75. Methodology
    Figure 76. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Osiris Therapeutics
NuVasive
Chiesi Pharmaceuticals
JCR Pharmaceutical
Pharmicell
Medi-post
Anterogen
Molmed
Takeda (TiGenix)

Related Reports

Global Stem Cell Therapy Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Global Stem Cell Therapy Market 2022 by Company, Regions, Type and Application, Forecast to 2028

date 04 Jan 2022

date Medical Care

The Stem Cell Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Stem Cell Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Stem Cell Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Medical Care

Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use.

Global Stem Cell Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Stem Cell Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Stem Cell Therapy market size was valued at USD 493.4 million in 2023 and is forecast to a readjusted size of USD 1652.9 million by 2030 with a CAGR of 18.9% during review period.

Global Stem Cell Therapy Supply, Demand and Key Producers, 2024-2030

Global Stem Cell Therapy Supply, Demand and Key Producers, 2024-2030

date 10 Feb 2024

date Medical Care

The global Stem Cell Therapy market size is expected to reach $ 1652.9 million by 2030, rising at a market growth of 18.9% CAGR during the forecast period (2024-2030).

Product Tags

animal stem cell therapy

stem cell therapy

cancer stem cell therapy

adipose derived stem cell therapy

adipose tissue derived stem cell therapy

allogeneic stem cell therapy

musculoskeletal disorder stem cell therapy

canine stem cell therapy

stem cell therapy for diabetes related conditions

stem cell therapy for multiple sclerosis

stem cell therapy for osteoarthritis

placental stem cell therapy

diabetes stem cell therapy

rheumatoid arthritis stem cell therapy

Adipose Tissue-derived Stem Cell Therapy

Stem Cell Therapy for Diabetes and Related Conditions

Stem Cell Therapy for Wound Healing

Stem Cell Therapy for Infertility

Placental Stem Cell Therapy for Neurological Disorders

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>